Lorrinda Gray-Davis is a liver transplant recipient, inoperable liver cancer survivor, and passionate advocate for organ transplant patients. She serves as Vice Chair of the Patient Affairs Committee for the Organ Procurement and Transplantation Network (OPTN) and is the President of the Transplant Recipients International Organization (TRIO). At the federal level, she serves on HRSA's Technical Expert Panel for Organ Procurement Organization Safety and Quality Standards and its Allocation Out of Sequence Committee.

Dr. Patidar is a Hepatologist and Transplant Hepatologist and Associate Professor of Medicine at Houston Methodist Hospital. He also serves as the Associate Director of Clinical Research for Academic Hepatology at Houston Methodist Hospital. He received his medical degree from West Virginia School of Osteopathic Medicine in 2012. He completed his residency in Internal Medicine and dual fellowships in Gastroenterology and Transplant Hepatology at Virginia Commonwealth University.

Dr. Holly Huang is a third-year Internal Medicine resident at the University of California, San Francisco (UCSF). Her research focuses on leveraging innovative technologies to improve access to and delivery of hepatology care.

I am a postdoctoral fellow at the University of Kansas Medical Center. My research focuses on alcohol-associated liver disease, bile acid metabolism, and the liver-gut axis. I am particularly interested in understanding the molecular mechanisms underlying liver and intestinal interactions in metabolic and liver diseases.

Armen Petrosyan, MD, PhD, is an Associate Professor in the Department of Biochemistry and Molecular Biology at the University of Nebraska Medical Center (UNMC). His research focuses on the cellular and molecular mechanisms of alcohol-associated liver disease (ALD), particularly how chronic alcohol exposure disrupts endoplasmic reticulum–Golgi homeostasis and contributes to hepatic inflammation and injury.